India approves Serum-Oxford, Bharat Biotech COVID vaccines for emergency use


India approves Serum-Oxford, Bharat Biotech COVID vaccines for emergency use

Two of the leading coronavirus vaccine contenders in India have been granted approval for restricted use.

Oxford-AstraZeneca’s coronavirus vaccine Covishield, manufactured by Serum Institute of India and Bharat Biotech’s COVID vaccine Covaxin have been approved for emergency use authorisation.

The Drug Controller General of India VG Somani said that the Central Drugs Standard Control Organisation (CDSCO) gave its approval followed by the recommendation of the Subject Expert Committee (SEC) that recommended both the vaccines for emergency use.
[…]
Source, english
Source, deutsch



Kommentar verfassen

Trage deine Daten unten ein oder klicke ein Icon um dich einzuloggen:

WordPress.com-Logo

Du kommentierst mit Deinem WordPress.com-Konto. Abmelden /  Ändern )

Twitter-Bild

Du kommentierst mit Deinem Twitter-Konto. Abmelden /  Ändern )

Facebook-Foto

Du kommentierst mit Deinem Facebook-Konto. Abmelden /  Ändern )

Verbinde mit %s